ARTA
MYOK

A.R.T. Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

A.R.T. Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,500
Closed -$148K – 1832
2016
Q4 		$148K Buy
+11,500
New +$177K 0.01% 1112

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

A.R.T. Advisors's MYOK Position: Q1 2017 in Review

A.R.T. Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2017, closing a stake of 11,500 shares — an estimated $148K sold.

A.R.T. Advisors first reported a position in MYOK in Q4 2016 and held it in 1 quarter. The position peaked at $148K in Q4 2016. 73 funds tracked by Wall St. Rank hold MYOK as of Q1 2017.

  • A.R.T. Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 11,500 MyoKardia, Inc. Common Stock shares in Q1 2017, an estimated $148K.
  • A.R.T. Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 1 quarter.
  • A.R.T. Advisors's MyoKardia, Inc. Common Stock position peaked at $148K in Q4 2016.
  • 73 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2017.

Based on A.R.T. Advisors's 13F filing for Q1 2017, filed 15 May 2017.